| # | Drug | Count |
|---|---|---|
| 0 | CALCIUM | 13 |
| 1 | CARVEDILOL | 13 |
| 2 | FULVESTRANT | 13 |
| 3 | LETROZOLE | 13 |
| 4 | LETROZOLE TABLETS | 13 |
| 5 | RIBOCICLIB | 13 |
| 6 | TELMISARTAN | 13 |
| 7 | ZOLEDRONIC ACID | 13 |
| 8 | ERGOCALCIFEROL | 12 |
| 9 | IBANDRONATE SODIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBANDRONATE SODIUM | 9 | 0.0029 |
| 1 | TELMISARTAN | 13 | 0.0007 |
| 2 | METHYLDOPA | 2 | 0.0004 |
| 3 | ERGOCALCIFEROL | 12 | 0.0004 |
| 4 | RIBOCICLIB | 13 | 0.0004 |
| 5 | FULVESTRANT | 13 | 0.0004 |
| 6 | ZOLEDRONIC ACID | 13 | 0.0003 |
| 7 | LETROZOLE TABLETS | 13 | 0.0003 |
| 8 | LETROZOLE | 13 | 0.0002 |
| 9 | GEMFIBROZIL | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 15 |
| 1 | Aromatase Inhibitor [EPC] | 13 |
| 2 | Calcium [EPC] | 13 |
| 3 | Estrogen Receptor Antagonist [EPC] | 13 |
| 4 | alpha-Adrenergic Blocker [EPC] | 13 |
| 5 | beta-Adrenergic Blocker [EPC] | 13 |
| 6 | Provitamin D2 Compound [EPC] | 12 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 8 | Calcium Channel Blocker [EPC] | 2 |
| 9 | Corticosteroid [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 1 | Estrogen Receptor Antagonist [EPC] | 13 | 0.0003 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Aromatase Inhibitor [EPC] | 13 | 0.0001 |
| 4 | alpha-Adrenergic Blocker [EPC] | 13 | 0.0001 |
| 5 | Calcium [EPC] | 13 | 0.0001 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 15 | 0.0000 |
| 7 | beta-Adrenergic Blocker [EPC] | 13 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |